These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5834938)

  • 1. Some central effects of SQ 10,643 [2'3-(-dimethlaminopropylthio) cinnamanilide hydrochloride], a potent serotonin antagonist.
    Furgiuele AR; High JP; Horovitz ZP
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):225-35. PubMed ID: 5834938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of some extracardiac effects of cardiac glycosides].
    Förster W; Sziegoleit W; Guhlke I
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):165-82. PubMed ID: 5834932
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of serotonin on brain metabolism.
    Mahler DJ; Humoller FL
    Int J Neuropsychiatry; 1967 Jun; 3(3):229-33. PubMed ID: 5298679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inhibitory effects of methyl o-(4-hydroxy-3-methoxycinnamoyl) reserpate (CD-3400) on the central nervous system (author's transl)].
    Shika K; Nakata C; Ogura M; Tamada T; Fujimoto Y
    Nihon Yakurigaku Zasshi; 1977 Oct; 73(7):717-34. PubMed ID: 23346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].
    Chiba S; Nagawa Y; Yui T
    Nihon Yakurigaku Zasshi; 1970; 66(1):64-75. PubMed ID: 4393359
    [No Abstract]   [Full Text] [Related]  

  • 6. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of reserpine, tetrabenzine and iproniazid on self-stimulation by rats.
    Haley TJ; Flesher AM; Komesu N
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):198-205. PubMed ID: 5646015
    [No Abstract]   [Full Text] [Related]  

  • 8. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological properties of some homologues of 5-methoxytryptamine].
    Arutiunian GS
    Farmakol Toksikol; 1967; 30(2):174-8. PubMed ID: 5628514
    [No Abstract]   [Full Text] [Related]  

  • 10. COMPARATIVE ACTIVITIES OF A SUBSTITUTED DIBENZOTHIAZEPINE, OF IMIPRAMINE AND OF DESIPRAMINE.
    HOROVITZ ZP; FURGIUELE AR; HIGH JP; BURKE JC
    Arch Int Pharmacodyn Ther; 1964 Sep; 151():180-91. PubMed ID: 14205411
    [No Abstract]   [Full Text] [Related]  

  • 11. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):94-107. PubMed ID: 5072195
    [No Abstract]   [Full Text] [Related]  

  • 13. Some effects of dl-4-(2-hydroxy-3-isopropylaminopropoxy) indole (LB46) on brain monoamines and their precursors.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):79-93. PubMed ID: 5072194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of serotonin, iproniazid, reserpine and 5-hydroxytryptophan on fibrinase activity].
    Polushkin BV
    Farmakol Toksikol; 1969; 32(3):318-20. PubMed ID: 5306960
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological action of FD-008, a new dopamine-beta-hydroxylase inhibitor.
    Ishii Y; Natsugoe K; Umezawa H
    Arzneimittelforschung; 1975 Feb; 25(2):213-5. PubMed ID: 1173034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral characterization of the new potent nonselective dopamine agonist pergolide.
    Helton DR; Modlin DL; Williams PD
    Arzneimittelforschung; 1992 Jul; 42(7):885-90. PubMed ID: 1418051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
    Kurumiya S; Miura Y; Nakatsuji K; Dodo M; Hori M; Ito T
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):225-31. PubMed ID: 2334465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of beta-phenylethylamine derivatives and serotonin blocking drugs upon serotonin, tryptamine and reserpine behavioral depression in mice.
    Saavedra JM; Fischer E
    Arzneimittelforschung; 1970 Jul; 20(7):952-7. PubMed ID: 5536068
    [No Abstract]   [Full Text] [Related]  

  • 19. [General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].
    Ochiai T; Yamamura M; Kudo Y; Ishida R
    Nihon Yakurigaku Zasshi; 1981 Oct; 78(4):347-57. PubMed ID: 7327455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological studies on 2-methyl-3(2'-methyl-4'-chlorophenyl)-5-chloro-4[H)-quinazolinone (SL-164).
    Saito C; Sakai S; Yukawa Y; Yamamoto H; Takagi H
    Arzneimittelforschung; 1969 Dec; 19(12):1945-9. PubMed ID: 4985336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.